Aging is arguably the root cause of most major diseases (loss of function in our cells). Four years ago, we made a bet that aging was treatable, and NewLimit was born.
NewLimit now has a prototype drug that reverses the age of some human cells (restores function they had when they were younger), and a clinical trial scheduled for next year (with more drug candidates in the pipeline).
Grateful to Founders Fund, Thrive, Greenoaks, and the rest of the investors for this latest round. @jacobkimmel and the team are just getting started.
Cannabis M&A is back.
But not as a wave of mega-mergers.
In 2026, the action is moving through private deals, distressed credit, all-stock transactions, earnouts, asset sales, and regional expansion.
Steve Jobs Called It Life's 'Single Best Invention' And 'The Destination We All Share': Apple Co-Founder Used This Insight To Achieve Daily Clarity https://t.co/WsPhI6KQgz $AAPL